These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 21446024)

  • 1. N-acetylcysteine prevents loss of dopaminergic neurons in the EAAC1-/- mouse.
    Berman AE; Chan WY; Brennan AM; Reyes RC; Adler BL; Suh SW; Kauppinen TM; Edling Y; Swanson RA
    Ann Neurol; 2011 Mar; 69(3):509-20. PubMed ID: 21446024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidative stress on EAAC1 is involved in MPTP-induced glutathione depletion and motor dysfunction.
    Aoyama K; Matsumura N; Watabe M; Nakaki T
    Eur J Neurosci; 2008 Jan; 27(1):20-30. PubMed ID: 18093171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuronal glutathione deficiency and age-dependent neurodegeneration in the EAAC1 deficient mouse.
    Aoyama K; Suh SW; Hamby AM; Liu J; Chan WY; Chen Y; Swanson RA
    Nat Neurosci; 2006 Jan; 9(1):119-26. PubMed ID: 16311588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EAAC1 gene deletion increases neuronal death and blood brain barrier disruption after transient cerebral ischemia in female mice.
    Choi BY; Kim JH; Kim HJ; Lee BE; Kim IY; Sohn M; Suh SW
    Int J Mol Sci; 2014 Oct; 15(11):19444-57. PubMed ID: 25350110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Depopulation of dense α-synuclein aggregates is associated with rescue of dopamine neuron dysfunction and death in a new Parkinson's disease model.
    Wegrzynowicz M; Bar-On D; Calo' L; Anichtchik O; Iovino M; Xia J; Ryazanov S; Leonov A; Giese A; Dalley JW; Griesinger C; Ashery U; Spillantini MG
    Acta Neuropathol; 2019 Oct; 138(4):575-595. PubMed ID: 31165254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased cysteine uptake by EAAC1 gene deletion exacerbates neuronal oxidative stress and neuronal death after traumatic brain injury.
    Choi BY; Kim IY; Kim JH; Lee BE; Lee SH; Kho AR; Jung HJ; Sohn M; Song HK; Suh SW
    Amino Acids; 2016 Jul; 48(7):1619-29. PubMed ID: 27040821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EAAC1 gene deletion alters zinc homeostasis and enhances cortical neuronal injury after transient cerebral ischemia in mice.
    Jang BG; Won SJ; Kim JH; Choi BY; Lee MW; Sohn M; Song HK; Suh SW
    J Trace Elem Med Biol; 2012 Jun; 26(2-3):85-8. PubMed ID: 22575539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.
    Novikova L; Garris BL; Garris DR; Lau YS
    Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Fcgamma receptors in nigral cell injury induced by Parkinson disease immunoglobulin injection into mouse substantia nigra.
    He Y; Le WD; Appel SH
    Exp Neurol; 2002 Aug; 176(2):322-7. PubMed ID: 12359173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of a alpha-synuclein-based rat model of Parkinson's disease.
    Recchia A; Rota D; Debetto P; Peroni D; Guidolin D; Negro A; Skaper SD; Giusti P
    Neurobiol Dis; 2008 Apr; 30(1):8-18. PubMed ID: 18313315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein kinase Cδ upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson's disease.
    Gordon R; Singh N; Lawana V; Ghosh A; Harischandra DS; Jin H; Hogan C; Sarkar S; Rokad D; Panicker N; Anantharam V; Kanthasamy AG; Kanthasamy A
    Neurobiol Dis; 2016 Sep; 93():96-114. PubMed ID: 27151770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conditional deletion of Ndufs4 in dopaminergic neurons promotes Parkinson's disease-like non-motor symptoms without loss of dopamine neurons.
    Choi WS; Kim HW; Tronche F; Palmiter RD; Storm DR; Xia Z
    Sci Rep; 2017 Mar; 7():44989. PubMed ID: 28327638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel role of aquaporin-4 in CD4+ CD25+ T regulatory cell development and severity of Parkinson's disease.
    Chi Y; Fan Y; He L; Liu W; Wen X; Zhou S; Wang X; Zhang C; Kong H; Sonoda L; Tripathi P; Li CJ; Yu MS; Su C; Hu G
    Aging Cell; 2011 Jun; 10(3):368-82. PubMed ID: 21255222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trisialoganglioside GT1b induces in vivo degeneration of nigral dopaminergic neurons: role of microglia.
    Ryu JK; Shin WH; Kim J; Joe EH; Lee YB; Cho KG; Oh YJ; Kim SU; Jin BK
    Glia; 2002 Apr; 38(1):15-23. PubMed ID: 11921200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombin-induced microglial activation produces degeneration of nigral dopaminergic neurons in vivo.
    Choi SH; Joe EH; Kim SU; Jin BK
    J Neurosci; 2003 Jul; 23(13):5877-86. PubMed ID: 12843292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minocycline Rescues from Zinc-Induced Nigrostriatal Dopaminergic Neurodegeneration: Biochemical and Molecular Interventions.
    Kumar V; Singh BK; Chauhan AK; Singh D; Patel DK; Singh C
    Mol Neurobiol; 2016 Jul; 53(5):2761-2777. PubMed ID: 25764516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pattern of neuronal loss and survival may reflect differential expression of proteasome activators in Parkinson's disease.
    McNaught KS; Jnobaptiste R; Jackson T; Jengelley TA
    Synapse; 2010 Mar; 64(3):241-50. PubMed ID: 19924695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibiting BDNF expression by antisense oligonucleotide infusion causes loss of nigral dopaminergic neurons.
    Porritt MJ; Batchelor PE; Howells DW
    Exp Neurol; 2005 Mar; 192(1):226-34. PubMed ID: 15698637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral N-acetyl-cysteine attenuates loss of dopaminergic terminals in alpha-synuclein overexpressing mice.
    Clark J; Clore EL; Zheng K; Adame A; Masliah E; Simon DK
    PLoS One; 2010 Aug; 5(8):e12333. PubMed ID: 20808797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nigral injection of a proteasomal inhibitor, lactacystin, induces widespread glial cell activation and shows various phenotypes of Parkinson's disease in young and adult mouse.
    Savolainen MH; Albert K; Airavaara M; Myöhänen TT
    Exp Brain Res; 2017 Jul; 235(7):2189-2202. PubMed ID: 28439627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.